Prognostic significance of post-clopidogrel platelet reactivity assessed by a point-of-care assay on thrombotic events after drug-eluting stent implantation.

By M. Price, Sarah W Endemann, Raghava R. Gollapudi, R. Valencia, C. Stinis, Justin P Levisay, Alissa Ernst, N. Sawhney, R. Schatz, P. Teirstein. European Heart Journal, 2008

666 citations recorded by the source corpus.

View Paper: https://www.semanticscholar.org/paper/691be3b52ee3308b76a29ea06b164b96ffd42038

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

1. L. Bonello
2. U. Tantry
3. N. Breet
4. R. Marcucci
5. Deepak L. Bhatt
6. R. Blindt
7. J. V. van Werkum
8. Richard C. Becker

Citations in the corpus

• Consensus and future directions on the definition of high on-treatment platelet reactivity to adenosine diphosphate. (2010, methodology): “t the present time, high on-treatment platelet reactivity in the etting of PCI has been defined by ROC analyses using the ollowing criteria: 1) PRI 50% by VASP-P analysis; 2) 235 o 240 P2Y12 reaction units by VerifyNow P2Y12 assay; 3) 46% maximal 5- mol/l ADP-induced aggregation; and 4) 468 arbitrar”
• Comparison of platelet function tests in predicting clinical outcome in patients undergoing coronary stent implantation. (2010, result): “However, the individual response to dual antiplatelet therapy is not uniform, and consistent findings across multiple investigations support the association between a lower degree of platelet inhibition, a high on-treatment platelet reactivity, and the occurrence of atherothrombotic events.(3-10) Th”